ATXS - Astria Therapeutics Director Trades $7.00M In Company Stock | Benzinga
PERCEPTIVE ADVISORS LLC, Director at Astria Therapeutics (NASDAQ:ATXS), reported a large insider buy on October 18, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LLC purchased 1,074,608 shares of Astria Therapeutics. The total transaction amounted to $6,999,996.
Astria Therapeutics shares are trading up 4.98% at $5.69 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however ...